Sign inGet started

Canepa John J

Insider CIK 1589238 · HART Director · CADL Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CADL Candel Therapeutics, Inc. A Award deriv2022-02-282022-03-01110,000— $0110,000SEC↗
CADL Candel Therapeutics, Inc. P Buy2021-07-292021-08-0210,125$8.00 $81.0K10,125SEC↗
BSTG Biostage, Inc. M Exercise deriv2018-03-142018-03-28912— $00SEC↗
BSTG Biostage, Inc. M Exercise2018-03-142018-03-28912— $01,774SEC↗
BSTG Biostage, Inc. A Award deriv2017-03-142017-03-1618,250— $018,250SEC↗
BSTG Biostage, Inc. A Award deriv2017-03-142017-03-1625,000— $025,000SEC↗
BSTG Biostage, Inc. P Buy2016-05-252016-05-2617,241$1.46 $25.2K17,241SEC↗
HART Harvard Apparatus Regenera A Award deriv2016-03-222016-03-2425,000— $025,000SEC↗
HART Harvard Apparatus Regenera A Award deriv2015-05-292015-06-0125,000— $025,000SEC↗
HART Harvard Apparatus Regenera A Award deriv2013-11-182013-11-1825,000— $025,000SEC↗